ArticleJournal of clinical medicine2025

Serum Hepcidin as a Biomarker of Subclinical Atherosclerosis in Peritoneal Dialysis: A Cross-Sectional Study.

Emina Kostić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.